.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In June 2026, Chill Medicated concentrated 63.82% of sales in Topical with year-over-year growth of 23.81% and a month-over-month dip of 2.90%, while Beverage held 33.91% share with 19.22% YoY and a 6.06% MoM contraction. Smaller bets moved fastest: Tincture & Sublingual reached 1.64% share with 112.05% YoY and 47.71% MoM growth, and Edible sat at 0.63% share with 76.13% YoY paired with a 52.30% MoM pullback. With a Topical rank of 1 in Michigan and an average price down 34.47% YoY to $21.89, the pattern implies price-led volume elasticity supporting category leadership while the portfolio relies on Topical scale and Beverage ballast.
The mix shift signals positioning anchored in pain-relief and wellness use cases in Topical (rank 1) while cultivating low-price, higher-frequency Beverage to defend reach as prices fall 34.47% YoY and Topical MoM slips 2.90%. The outsized Tincture & Sublingual acceleration (112.05% YoY and 47.71% MoM) versus Beverage’s 6.06% MoM decline suggests an emerging efficacy-seeking cohort that could diversify reliance on the 63.82% Topical share, and Edible’s 52.30% MoM drop despite 76.13% YoY growth indicates promotional or seasonal volatility rather than durable mix expansion; together, these shifts imply a barbell: defend Topical rank 1 while nurturing Tincture & Sublingual as the next leg of mix resilience.
Competitive Landscape
Chill Medicated sits at rank #1 in MI Topical in June 2026 with no year-over-year rank change from #1, and it also held #1 three months ago, indicating zero movement across both the annual and quarterly comparisons; in contrast, Mary's Medicinals is stable at #2 year over year while Escape Artists moved from #6 to #5, and Rise (MI) remains at #3 despite a -49.43% sales change. With peers either holding (#2 to #2 for Mary's Medicinals) or making only incremental gains (#6 to #5 for Escape Artists), the absence of rank volatility for Chill Medicated at #1 across both year-over-year and three-month views implies entrenched category leadership that competitors have not materially closed.
Notable Products
Blue Raspberry Syrup (200mg THC, 4oz) posted the steepest decline at -34.1% month over month, dropping to rank 8, while Grape Syrup (200mg) fell -25.4% to rank 5. In contrast, Chill To Go - Watermelon Live Rosin Syrup (200mg) climbed 31.4% to rank 4 and Chill To Go - Grape Live Rosin Syrup (200mg) rose 15.8% to rank 3. Eight of the top ten SKUs are Beverage syrups, yet the CBD/THC 1:1 Extreme X Body Rub (2000mg CBD, 2000mg THC, 2.5oz) still holds rank 1 despite a -4.7% dip and the Maxx - CBD/THC 1:1 Medicated Body Rub (1000mg CBD, 1000mg THC, 2.5oz) sits at rank 10 with +5.5%. The pattern implies a portfolio leaning on Beverage breadth for volume but anchoring revenue with Topical leaders, suggesting June 2026 assortment should prioritize stabilizing legacy syrups while protecting high-ticket Topicals at $285,055.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
